abstract |
Remedies for psychoneurosis which are useful in treating nervous diseases, in particular, restless legs syndrome. These remedies contain, as the active ingredient, opioid λ receptor agonistic compounds (excluding pentazocine) such as (-)-17-(cyclopropylmethyl)-3,14β-dihydroxy-4,5α-epoxy-6β [N-methyl-trans-3-(3-furyl)acrylamido]morphinane hydrochloride. |